Objectives: To determine whether temporal patterns of hypoglycaemia exist in inpatients with diabetes 'at risk' of hypoglycaemia (those on insulin and/or sulfonylureas), and if so whether patterns differ between hospitals and between these treatments.
Setting: Retrospective multicentre audit of inpatients with diabetes involving 11 acute UK National Health Service (NHS) trusts.
Participants: Capillary blood glucose readings of 3.9 mmol/L or less (hypoglycaemia) for all adult (≥18 years) inpatients with diabetes 'at risk' of hypoglycaemia were extracted from the Abbott PrecisionWeb Point-of-Care Data Management System over a 4-week period. Overall, 2521 readings of 3.9 mmol/L or less (hypoglycaemia) occurring in 866 participants between 1 June 2013 and 29 June 2013 were analysed.
Results: The majority (65%) occurred between 21:00 and 08:59, a pattern common to all Trusts. This was more frequent in sulfonylurea-treated than insulin-treated participants (75.3% vs 59.3%, p=0.0001). Furthermore, hypoglycaemic readings were more frequent between 5:00 and 7:59 in sulfonylurea-treated than insulin-treated participants (46.7% vs 22.7% of readings for respective treatments, p=0.0001). Sulfonylureas accounted for 31.8% of all hypoglycaemic readings. As a group, sulfonylurea-treated participants were older (median age 78 vs 73 years, p=0.0001) and had lower glycated haemoglobin (median 56 (7.3%) vs 69 mmol/mol (8.5%), p=0.0001). Hypoglycaemic readings per participant were as frequent for sulfonylurea-treated participants as for insulin-treated participants (median=2 for both) as were the proportions in each group with ≥5 hypoglycaemic readings (17.3% vs 17.7%).
Conclusions: In all Trusts, hypoglycaemic readings were more frequent between 21:00 and 08:59 in 'at risk' inpatients with diabetes, with a greater frequency in the early morning period (5:00-7:59) in sulfonylurea-treated inpatients. This may have implications for the continuing use of sulfonylureas in the inpatient setting.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091462 | PMC |
| http://dx.doi.org/10.1136/bmjopen-2014-005165 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
An Insulin Upstream Open Reading Frame (INSU) Is Present in Skeletal Muscle Satellite Cells: Changes with Age.
Cells
November 2024
Intramural Research Program, National Institute on Aging, National Institutes of Health, 251 Bayview Blvd, Baltimore, MD 21224, USA.
Insulin resistance, stem cell dysfunction, and muscle fiber dystrophy are all age-related events in skeletal muscle (SKM). However, age-related changes in insulin isoforms and insulin receptors in myogenic progenitor satellite cells have not been studied. Since SKM is an extra-pancreatic tissue that does not express mature insulin, we investigated the levels of insulin receptors (INSRs) and a novel human insulin upstream open reading frame (INSU) at the mRNA, protein, and anatomical levels in Baltimore Longitudinal Study of Aging (BLSA) biopsied SKM samples of 27-89-year-old (yrs) participants.
View Article and Find Full Text PDFObjective: To evaluate whether continuous glucose monitoring (CGM) could assist providers in intensifying glycemic management in hospitalized patients with type 2 diabetes.
Research Design And Methods: At six academic hospitals, adults with type 2 diabetes hospitalized in a non-intensive care setting were randomly assigned to either standard therapy with glucose target 140-180 mg/dL (standard group) or intensive therapy with glucose target 90-130 mg/dL guided by CGM (intensive group). The primary outcome was mean glucose measured with CGM (blinded in standard group), and the key secondary outcome was CGM glucose <54 mg/dL.
Comparing dual oral agents plus insulin vs. Triple oral agents in uncontrolled type II diabetes: A pilot study.
PLoS One
November 2024
Department of Pharmacy Practice, College of Clinical Pharmacy, King Faisal University, Al Ahsa, Saudi Arabia.
Introduction: Type II Diabetes mellitus (T2DM) patients often do not achieve glycemic control with oral hypoglycemic agents (OHAs). There are two main approaches to address this challenge: transitioning to a triple OHA regimen, or adding Insulin to the existing dual OHA regimen.
Aim: This study aimed to compare the efficacy of adding Insulin to dual OHAs (Sitagliptin + Metformin) against adding a third OHA to Sitagliptin + Metformin in achieving glycemic control among patients with uncontrolled T2DM.
Akt regulates the fertility of Coridius chinensis by insulin signaling pathway.
Sci Rep
November 2024
Guizhou Provincial Key Laboratory for Agricultural Pest Management of Mountainous Regions, Institute of Entomology, Guizhou University, 550025, Guizhou, China.
Article Synopsis
- Akt, a crucial protein in the insulin signaling pathway, was cloned and characterized from Coridius chinensis (CcAkt), revealing its potential role in reproduction.
- The gene encodes 520 amino acids and shows high expression levels in female adults and certain developmental stages, influenced by hormones like insulin and methoprene.
- Knockdown of CcAkt in unmated females led to reduced expression of reproductive-related genes and negatively impacted ovary development, egg production, and hatch rates, indicating its regulatory role in reproduction.
Improved Localization of Insulinomas Using Ga-NODAGA-Exendin-4 PET/CT.
J Nucl Med
December 2024
Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
Article Synopsis
- The study compares the effectiveness of Ga-NODAGA-exendin-4 PET/CT to traditional imaging methods for locating insulinomas, a type of tumor that causes low blood sugar.
- Exendin PET/CT showed a significantly higher diagnostic accuracy (94.4%) compared to DOTA-SSA PET/CT (64.8%), CT/MRI (83.3%), and endoscopic ultrasound (82.8%).
- The findings suggest that exendin PET/CT offers better image quality and consistency among observers, making it a valuable tool for the preoperative assessment of insulinomas.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!